ArticlePharmaceuticals (Basel, Switzerland)2026
Mechanistic Exploration of
Alejandro I Recio-Balsells, Chantal Reigada, María Gabriela Mediavilla, Esteban Panozzo-Zénere, Miguel Villarreal Parra, Patricia S Doyle, Juan C Engel, Claudio A Pereira, Julia A Cricco, Guillermo R Labadie
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Alejandro I Recio-BalsellsInstituto de Química Rosario (IQUIR-CONICET-UNR), Suipacha 531, Rosario 2000, Argentina.ORCID 0000-0002-9688-4589 Chantal ReigadaFacultad de Medicina, Instituto de Investigaciones Médicas A. Lanari, Universidad de Buenos Aires, Buenos Aires 1113, Argentina.ORCID 0000-0002-8844-8517 María Gabriela MediavillaInstituto de Biología Molecular y Celular de Rosario (IBR-CONICET-UNR), Ocampo y Esmeralda, Rosario 2000, Argentina.
Esteban Panozzo-ZénereInstituto de Química Rosario (IQUIR-CONICET-UNR), Suipacha 531, Rosario 2000, Argentina.
Miguel Villarreal ParraInstituto de Química Rosario (IQUIR-CONICET-UNR), Suipacha 531, Rosario 2000, Argentina.
Patricia S DoyleDepartment of Pathology, Sandler Center for Drug Discovery, University of California San Francisco, San Francisco, CA 94158-2330, USA.
Juan C EngelDepartment of Pathology, Sandler Center for Drug Discovery, University of California San Francisco, San Francisco, CA 94158-2330, USA.
Claudio A PereiraFacultad de Medicina, Instituto de Investigaciones Médicas A. Lanari, Universidad de Buenos Aires, Buenos Aires 1113, Argentina.
Julia A CriccoInstituto de Biología Molecular y Celular de Rosario (IBR-CONICET-UNR), Ocampo y Esmeralda, Rosario 2000, Argentina.ORCID 0000-0002-8993-3880 Guillermo R LabadieInstituto de Química Rosario (IQUIR-CONICET-UNR), Suipacha 531, Rosario 2000, Argentina.ORCID 0000-0003-2467-1573 Funding
Agencia Nacional de Promoción Científica y Tecnológica, Argentina PICT 2019-02622Agencia Nacional de Promoción Científica y Tecnológica, Argentina PICT 2021-I-A-00512CONICET PIBAA 28720210100409CONICET PIP 2021-2023 11220200101045COUK Research and Innovation, Global Challenges Research Fund MR/P027989/1Universidad Nacional de Rosario 80020190300101UR
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
amastigote inhibitionChagas diseasedisubstituted diaminesneglected diseasespolyamine transport
Identifiers
PMID41599717
PMCPMC12845068
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390